Key facts
- Anupam Rasayan India Ltd. has successfully commercialized the production of Ethyl trifluoroacetate (ETFA).
- The company is the first in the world to use a continuous flow chemistry platform for ETFA manufacturing at a commercial scale.
- This technology offers improved safety, reproducibility, scalability, efficiency, and a reduced environmental footprint.
- ETFA is a critical fluorinated building block for pharmaceuticals, life sciences, and performance materials.
- The global market for ETFA is estimated between $500 million and $600 million.
Specialty chemicals maker Anupam Rasayan India Ltd. announced on Friday that it has successfully commercialized the production of Ethyl trifluoroacetate (ETFA) using its proprietary continuous flow chemistry platform. This achievement makes the company the first globally to manufacture the compound at a commercial scale via this advanced technology.
The Gujarat-based firm highlighted that its continuous flow platform provides significant advantages over conventional batch processes. These benefits include enhanced process safety, superior reproducibility, improved scalability, higher operational efficiency, and a lower environmental footprint.
ETFA is described as a critical fluorinated building block and reagent essential for synthesizing a wide array of organic fluorine compounds. These compounds find extensive applications across the pharmaceutical, life sciences, and performance materials sectors. The company estimates the global addressable market for ETFA to be approximately USD 500-600 million.